Lupin Limited has received recommendations from the Subject Expert Committee (SEC) under the Central Drugs Standard Control ...

Indias top drugmakers, Sun Pharmaceutical Industries (NSE:SUN) and Lupin Ltd (NSE:LUPN), are moving closer to developing ...

Mumbai: Lupin has announced that the U.S. Food and Drugs Administration (USFDA) has closed the inspection with six ...

Lupin shares declined nearly 2% on Wednesday on news that the US Food and Drug Administration (USFDA) issued six observations ...

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) is among the fastest growing small cap stocks to buy. Lupin Inc., a leading player in ...

Lupin has received USFDA approval to market generic Lenalidomide capsules, a version of Bristol-Myers Squibb's cancer drug Revlimid, which posted $7.5 bn US sales in July 2025 ...

Lenalidomide Capsules are indicated for the treatment of adult patients with Multiple myeloma, in combination with ...

USFDA inspections at Lupin, Zydus, and Aurobindo facilities result in observations, commitment to compliance with quality ...

Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced ...

In its base case, Investec expects a strong FY26, followed by moderation in FY27, with EPS growth resuming in FY28. In the ...

Indian pharma stocks lag Nifty in 2025 as US demand, pricing pressure and FDA scrutiny weigh; domestic growth offers some ...

Nevertheless, pharma companies will sustain their growth and profitability during FY26 due to strong domestic formulations, ...